Search for Clinical Trial Results
Ovarian Low Malignant Potential Tumor - 17 Studies Found
Status | Study |
Completed |
Study Name: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors Condition:
|
Recruiting |
Study Name: Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer Condition:
Interventions: |
Completed |
Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer Condition: Cancer Date: 2002-09-06 Interventions: Drug: vorinostat |
Completed |
Study Name: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer Condition:
|
Completed |
Study Name: Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer Condition:
Date: 2006-09-29 Interventions:
|
Completed |
Study Name: Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer Condition: Ovarian Cancer Date: 2001-07-11 Interventions:
|
Completed |
Study Name: Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors Condition:
|
Completed |
Study Name: Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors Condition:
Interventions: |
Completed |
Study Name: LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer Condition:
Interventions: Biological: LMB-9 immunotoxin |
Completed |
Study Name: BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer Condition:
|